A

Amphastar Pharmaceuticals
D

AMPH

31.260
USD
-0.07
(-0.22%)
مغلق
حجم التداول
17,900
الربح لكل سهم
0
العائد الربحي
-
P/E
10
حجم السوق
1,503,025,596
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    AAL
    -0.635
    (-4.00%)
    15.225 USD
    A
    AIT
    -18.130
    (-6.87%)
    245.700 USD
    A
    ALK
    -5.140
    (-6.82%)
    70.210 USD
    BA
    BA
    -3.550
    (-1.96%)
    177.320 USD
    DAL
    DAL
    -3.770
    (-5.91%)
    59.980 USD
    HEI
    HEI
    -0.020
    (-0.01%)
    225.560 USD
    L
    LUV
    -0.805
    (-2.63%)
    29.800 USD
    TDG
    TDG
    -22.91
    (-1.75%)
    1,289.99 USD
    U
    UAL
    -6.540
    (-6.38%)
    95.930 USD
    المزيد
الأخبار
المقالات

العنوان: Amphastar Pharmaceuticals

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has tworeportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.